Home » Topics » Disease categories and therapies » Dental

Dental
RSS

CollaGenex seeks FDA approval for new dosage form of Periostat

April 5, 2000

Xanthine-based cell adhesion inhibitors particularly useful for periodontitis

March 24, 2000

Periostat receives U.K. marketing approval for treatment of chronic adult periodontitis

March 1, 2000

Periodontix raises funding for further development of HistaWash

Jan. 21, 2000

Atridox periodontal therapy approved in E.U.

Jan. 6, 2000

PAX9 gene mutation results in missing teeth

Jan. 5, 2000

Cathepsin C may be an important mediator in the development of periodontitis

Dec. 16, 1999

Positive phase III trial results for OraPharma's periodontal disease treatment

Dec. 1, 1999

Taiho prepares novel agents for periodontitis

Nov. 11, 1999

Atrix reports postmarketing study results for Atridox periodontitis therapy

Sep. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...